REFLOW Study, Investigating the Efficacy of the LEGFLOW DCB in TASC C&D Fempop Lesions

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 120 participants.

Also called NCT02580955

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02580955
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Belgium (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02580955. Allocation not applicable; no masking; primary purpose treatment. Start 2015-10 (registry gives no type); primary completion 2019-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
REFLOW Study, Investigating the Efficacy of the LEGFLOW DCB in TASC C&D Fempop Lesions
Condition
Peripheral Arterial Disease
Intervention (Device)
LEGFLOW DCB
Lead sponsor
Flanders Medical Research Program (class: research network)

Record details

Record id
cardio:ct-nct02580955
Content hash
c57bf4a75ff22c3765d66e0cd966447badd1ef34e5aeb4bbf36b8aeda416d096